Results 251 to 260 of about 145,684 (315)

Sulfasalazine, IBD, and pregnancy

Gastroenterology, 1981
openaire   +2 more sources

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study

Alimentary Pharmacology &Therapeutics, EarlyView.
In a real‐world cohort of patients with highly refractory perianal Crohn's disease, upadacitinib induced clinical remission at 12 months in 26% of patients with fistulizing disease and 25% of those with isolated anal ulcerations. ABSTRACT Introduction Upadacitinib (UPA) is effective for treating luminal Crohn's disease (CD), but data on perianal CD ...
Nicolas Richard, Philippe Seksik, Romain Altwegg, Maria Nachury, David Laharie, Stéphane Nancey, Benoît Coffin, Anne‐Laure Pelletier, Mathieu Uzzan, Aurélien Amiot, Morgane Amil, Lucine Vuitton, Mathurin Fumery, Anne Bozon   +13 more
wiley   +1 more source

A Care Pathway for the Treatment of IBD Reduces Healthcare Costs and Is Cost‐Effective: Results of the Multicentre IBD Value Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This study provides real‐world evidence that implementing an advanced therapy care pathway for patients with IBD leads to significant healthcare cost savings without compromising quality of life. These findings support broader implementation of care pathways in the management of patients with chronic conditions to optimise care delivery and resource ...
Elyke H. Visser, Martijn. A. Oude Voshaar, Reinier C. A. van Linschoten, Alexander G. L. Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K. Evelyne Verweij, Sanne van der Wiel, Daniëlle van der Horst, C. Janneke van der Woude, R. L. West, D. van Noord   +12 more
wiley   +1 more source

Incidence of <i>Clostridium difficile</i> infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation. [PDF]

Front Pediatr
Al-Shaibah K, Jasem R, Alsarhan A, Tzivinikos C.   +3 more
europepmc   +1 more source

"She just wants to be a normal kid": Adolescents with inflammatory bowel disease and their caregivers' transition from paediatric to adult care. [PDF]

Br J Health Psychol
de Gooyer M, Mackay MI, Mikocka-Walus A, Biurra YC, Emerson C, Klas A, Raven L, Massuger W, Giles EM, Evans S.   +9 more
europepmc   +1 more source

Prevalence, patient characteristics, and outcomes of high-dose upadacitinib in inflammatory bowel disease. [PDF]

Ther Adv Gastroenterol
Azar J, Johnkennedy R, Levine LJ, AlOmar I, AlMutairdi A, Attamimi M, Proctor DD, Gaidos JKJ, Al-Bawardy B.   +8 more
europepmc   +1 more source

The role and targeting potential analysis of angiogenesis-related target THY1 in DSS-induced acute colitis in mice. [PDF]

PLoS One
Zhang P, Liu X, Chen S, Zhang Y.
europepmc   +1 more source

Prevalence and Clinical Correlates of Psychiatric Disorders in a Hispanic-Majority Inflammatory Bowel Disease Cohort. [PDF]

Cureus
Orosa M, Xu M, Chang A.
europepmc   +1 more source

Listening to the Body: Interoceptive Awareness and Eating Disorder Vulnerability in Adolescents with Inflammatory Bowel Diseases. [PDF]

Children (Basel)
Riva A, Arienti G, Di Guardo S, Brasola E, Zuin G, Spini L, Sansotta N, Cavanna AE, Nacinovich R.   +8 more
europepmc   +1 more source